LLMpediaThe first transparent, open encyclopedia generated by LLMs

Azurion

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Philips Hop 4
Expansion Funnel Raw 67 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted67
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Azurion
NameAzurion
ManufacturerPhilips
ClassificationInterventional imaging system
Used inCardiology, Radiology, Surgery
RelatedX-ray, Fluoroscopy, Angiography

Azurion. Azurion is a premium image-guided therapy platform developed by the multinational technology corporation Philips. Designed as a highly adaptable system, it integrates advanced imaging modalities like fluoroscopy and digital subtraction angiography with sophisticated procedural navigation to support minimally invasive interventions. The platform is utilized globally in hospital settings, particularly within catheterization labs and hybrid operating rooms, to treat complex conditions in fields such as interventional cardiology, neurointerventional surgery, and oncology.

Overview

The Azurion platform represents a significant evolution in interventional radiology and image-guided surgery, providing a unified environment for planning, guidance, and treatment. Its core function is to deliver high-quality real-time imaging, which is critical for procedures like percutaneous coronary intervention and transcatheter aortic valve implantation. The system is engineered to enhance clinical confidence and workflow efficiency for physicians at leading institutions like the Cleveland Clinic and Mayo Clinic. By offering customizable configurations, it can be tailored to support a wide spectrum of procedures from routine angiography to complex endovascular aneurysm repair.

Clinical Applications

Azurion is extensively employed across multiple medical specialties for diagnostic and therapeutic procedures. In cardiology, it is fundamental for visualizing coronary artery disease and guiding stent placements during interventions often studied in trials like SYNTAX. For neurovascular applications, it aids in the treatment of cerebral aneurysms and acute ischemic stroke through mechanical thrombectomy. Within vascular surgery, the system supports endovascular repairs for conditions like abdominal aortic aneurysm. Furthermore, its applications extend to interventional oncology for procedures such as radiofrequency ablation and chemoembolization of hepatic tumors.

Technical Specifications

The platform's imaging capabilities are anchored by its Flat-panel detector technology, which provides high-resolution digital imaging with low radiation dose. It features advanced image processing algorithms, including ClarityIQ for enhanced image quality and DoseWise for radiation management, aligning with standards from the International Commission on Radiological Protection. The system supports 2D, 3D, and live 3D imaging, facilitated by rotational acquisitions like Spin Angiography. Its integration with computed tomography and magnetic resonance imaging data allows for advanced fusion imaging, crucial for complex navigation in procedures referenced in journals like the Journal of Vascular and Interventional Radiology.

System Components

Key hardware elements of the Azurion platform include a ceiling-mounted C-arm system with a wide range of motion for optimal patient access, a responsive table system, and large flat-panel monitors for displaying multimodal data. The user interface is centralized through the FlexArm and Touch Screen console, allowing intuitive control of imaging parameters and system positioning. The platform also incorporates specialized software suites such as EPIQ for advanced echocardiography integration and IntelliSpace Portal for comprehensive procedural planning. These components are designed to interoperate seamlessly within the Azurion with FlexArm and Azurion with FlexVision configurations.

Development and History

The development of Azurion was driven by Philips Healthcare's long-standing expertise in medical imaging, building upon predecessors like the Allura Xper FD systems. Its design philosophy focused on creating a flexible platform to address the growing complexity of minimally invasive therapies, a trend highlighted at conferences like the Radiological Society of North America annual meeting. The system was officially launched in 2017, with subsequent iterations introducing enhancements in workflow automation and imaging intelligence. Its development involved collaborations with clinical partners across the European Society of Cardiology network and has been featured in studies published in Circulation: Cardiovascular Interventions.

Comparison with Other Systems

Within the competitive landscape of image-guided therapy systems, Azurion is often compared to platforms like Siemens Healthineers' Artis pheno and GE Healthcare's Discovery IGS. A key differentiator is its emphasis on modularity and scalability, allowing hospitals to tailor the system to specific departmental needs, from a cardiac catheterization lab to a neurosurgery suite. While systems like the Artis Q excel in high-speed imaging, Azurion competes by offering a broad ecosystem of integrated applications and a user-centric design aimed at improving ergonomics and reducing procedural times, as analyzed in reviews by experts like those at EuroPCR.

Category:Medical equipment Category:Medical imaging Category:Philips